Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-037464
Filing Date
2012-06-20
Accepted
2012-06-20 21:36:47
Documents
2
Period of Report
2012-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd349304.html 3  
1 FORM 3 rrd349304.xml 3 5723
2 POWER OF ATTORNEY rrd313429_353859.htm EX-24. 3278
  Complete submission text file 0001181431-12-037464.txt   10465
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 12918320